Profile data is unavailable for this security.
About the company
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.
- Revenue in NZD (TTM)1.96bn
- Net income in NZD520.50m
- Incorporated1954
- Employees6.90k
- LocationFisher & Paykel Healthcare Corporation Ltd15 Maurice Paykel Place, East TamakiAUCKLAND 1061New ZealandNZL
- Phone+64 95740100
- Fax+64 95740158
- Websitehttps://www.fphcare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai MicroPort MedBot Group Co Ltd | 0.00 | -92.79m | 9.69bn | 756.00 | -- | 33.20 | -- | -- | -0.5166 | -0.5166 | 0.00 | 1.62 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.67 | -7.17 | 0.0358 | -- | -- | -- | -199.24 | -- | -- | -- |
| MicroPort Scientific Corporation | 1.07bn | -317.33m | 11.00bn | 8.30k | -- | 5.07 | -- | 10.30 | -0.933 | -0.933 | 3.14 | 6.32 | 0.275 | 1.11 | 4.49 | 801,344.80 | -10.19 | -2.34 | -13.99 | -3.49 | 64.16 | 69.95 | -37.07 | -4.89 | 5.51 | -5.30 | 0.3197 | -- | -18.24 | 11.54 | -513.24 | -- | 23.14 | -- |
| Angelalign Technology Inc | 249.12m | 42.73m | 11.36bn | 1.57k | 248.64 | 17.11 | 224.97 | 45.59 | 1.44 | 1.44 | 8.36 | 20.92 | -- | -- | -- | 1,015,262.00 | -- | -- | -- | -- | 68.67 | -- | 17.17 | -- | 4.88 | -- | 0.0058 | -- | 26.42 | -- | 118.91 | -- | -- | -- |
| Cochlear Limited | 1.56bn | 340.69m | 14.68bn | 4.00k | 43.07 | 8.27 | 34.66 | 9.40 | 4.97 | 4.97 | 22.78 | 25.88 | 0.5974 | 1.81 | 5.63 | 374,400.00 | 13.02 | 10.58 | 17.21 | 14.47 | 73.38 | 73.92 | 21.80 | 12.25 | 2.52 | -- | 0.1344 | 92.65 | 13.40 | 5.78 | 237.01 | 11.56 | 14.09 | 2.09 |
| Fisher & Paykel Healthcare Corp Ltd | 1.96bn | 520.50m | 19.24bn | 6.90k | 36.70 | 11.95 | 32.00 | 9.81 | 0.8978 | 0.8978 | 3.38 | 2.76 | 1.07 | 2.70 | 8.26 | 284,326.50 | 28.31 | 23.13 | 34.39 | 28.55 | 63.81 | 65.33 | 26.54 | 22.33 | 1.83 | -- | 0.0671 | 53.79 | 55.99 | 19.31 | 82.46 | 29.59 | 22.94 | 17.87 |
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (World Investors)as of 13 Aug 2020 | 30.81m | 5.34% |
| First Sentier Investors (Australia) IM Ltd.as of 22 Sep 2021 | 20.67m | 3.58% |
| BlackRock Fund Advisorsas of 09 Jul 2021 | 19.86m | 3.44% |
| The Vanguard Group, Inc.as of 05 Nov 2021 | 14.37m | 2.49% |
| Guardians of New Zealand Superannuationas of 30 Jun 2021 | 13.37m | 2.32% |
| Accident Compensation Corp.as of 27 Apr 2021 | 9.62m | 1.67% |
| Norges Bank Investment Managementas of 31 Dec 2020 | 9.05m | 1.57% |
| Milford Asset Management Ltd.as of 31 Oct 2021 | 8.93m | 1.55% |
| AMP Capital Investors (New Zealand) Ltd.as of 29 Oct 2021 | 6.32m | 1.10% |
| BlackRock Investment Management (Australia) Ltd.as of 09 Jul 2021 | 6.12m | 1.06% |
